These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 4579935)

  • 41. Inhibition of pituitary response to gonadotropin releasing hormone by urinary gonadotropin inhibiting substance.
    Damian E; Ianăş O; Bădescu I; Oprescu M
    Endocrinologie; 1981; 19(1):29-32. PubMed ID: 6794139
    [TBL] [Abstract][Full Text] [Related]  

  • 42. (Des-Gly-NH 10 2 , pro-ethylamide 9 )-LH-RH: a highly potent analog of luteinizing hormone releasing hormone.
    Fujino M; Shinagawa S; Yamazaki I; Kobayashi S; Obayashi M; Fukuda T; Nakayama R; White WF; Rippel RH
    Arch Biochem Biophys; 1973 Jan; 154(1):488-9. PubMed ID: 4570238
    [No Abstract]   [Full Text] [Related]  

  • 43. Pituitary response to gonadotropin-releasing hormone (Gn-RH) stimulation in normal subjects.
    Lafuenti G; Serra GB; Palla GP
    Folia Endocrinol; 1973 Jun; 26(3):180-8. PubMed ID: 4580658
    [No Abstract]   [Full Text] [Related]  

  • 44. Pituitary and gonadal responses to continuous infusion of gonadotropin releasing hormone in the male bullfrog, Rana catesbeiana.
    Mc Creery BR; Licht P
    Biol Reprod; 1983 Aug; 29(1):129-36. PubMed ID: 6351936
    [No Abstract]   [Full Text] [Related]  

  • 45. LH-RH interaction with the pituitary plasma membrane.
    Spona J
    FEBS Lett; 1973 Aug; 34(1):24-6. PubMed ID: 4580997
    [No Abstract]   [Full Text] [Related]  

  • 46. Microcomputer-controlled device for delivering hormone stimulation to cell suspensions in perifusion: release of luteinising hormone from sheep pituitary cells.
    McIntosh JE; McIntosh RP; Kean RJ
    Med Biol Eng Comput; 1984 May; 22(3):259-62. PubMed ID: 6376966
    [No Abstract]   [Full Text] [Related]  

  • 47. Changes in LH levels in the internal jugular vein following intracarotid injection of purified LH-releasing factor in spayed rats.
    Héry M; Kerdelhue B; Pattou E; Jutisz M; Kordon C
    Life Sci I; 1972 Sep; 11(17):809-15. PubMed ID: 4570798
    [No Abstract]   [Full Text] [Related]  

  • 48. Effect of purified luteinizing hormone releasing factor on normal and hypogonadotrophic anosmic men.
    Naftolin F; Harris GW; Bobrow M
    Nature; 1971 Aug; 232(5311):496-7. PubMed ID: 4937217
    [No Abstract]   [Full Text] [Related]  

  • 49. Clinical evaluation in men of a substance with growth hormone-releasing activity.
    Kastin AJ; Schally AV; Gual C; Glick S; Arimura A
    J Clin Endocrinol Metab; 1972 Aug; 35(2):326-9. PubMed ID: 4561197
    [No Abstract]   [Full Text] [Related]  

  • 50. Gonadotrophin-releasing hormone: its actions and receptors.
    Clayton RN
    J Endocrinol; 1989 Jan; 120(1):11-9. PubMed ID: 2537367
    [No Abstract]   [Full Text] [Related]  

  • 51. Pituitary and plasma growth hormone-like activity after administration of highly purified pig growth hormone-releasing factor.
    Sawano S; Arimura A; Bowers CY; Redding TW; Schally AV
    Proc Soc Exp Biol Med; 1968 Apr; 127(4):1010-4. PubMed ID: 4871941
    [No Abstract]   [Full Text] [Related]  

  • 52. Fall in plasma-testosterone levels in normal male subjects in response to an oral glucose load.
    Wall JR; Jarrett RJ; Zimmet PZ; Bailes M; Ramage CM
    Lancet; 1973 May; 1(7810):967-8. PubMed ID: 4121588
    [No Abstract]   [Full Text] [Related]  

  • 53. Molecular composition of human luteinizing hormone: biological and immunological profiles of highly purified preparations after electrofocusing.
    Zaidi AA; Qazi MH; Diczfalusy E
    J Endocrinol; 1982 Jul; 94(1):29-36. PubMed ID: 7097144
    [No Abstract]   [Full Text] [Related]  

  • 54. A genetic study of luteinizing hormone levels and induced lutenizing hormone release in male mice.
    Sustarsic DL; Wolfe HG
    J Hered; 1979; 70(4):226-30. PubMed ID: 489950
    [No Abstract]   [Full Text] [Related]  

  • 55. Assessment of pituitary function.
    Hockaday TD
    Br Med J (Clin Res Ed); 1983 Dec; 287(6407):1738-40. PubMed ID: 6416570
    [No Abstract]   [Full Text] [Related]  

  • 56. Evidence for partial refractoriness of the human pituitary.
    Schneider HP; Dahlén HG
    Acta Endocrinol Suppl (Copenh); 1973; 173():86. PubMed ID: 4579935
    [No Abstract]   [Full Text] [Related]  

  • 57. Sensitivity of the anterior pituitary gland to luteinizing hormone releasing factor (LRF) during pro-oestrus in the rat.
    Aiyer MS; Fink G; Greig F
    J Physiol; 1973 May; 231(1):32P-34P. PubMed ID: 4577103
    [No Abstract]   [Full Text] [Related]  

  • 58. Pharmacological characteristics of a synthetic releasing hormone LH-FSH-RH (Hoe 471). I. Release of luteinizing hormone.
    Sandow J; Schally AV; Schröder HG; Redding TW; Heptner W; Vogel HG
    Arzneimittelforschung; 1972 Oct; 22(10):1718-21. PubMed ID: 4577395
    [No Abstract]   [Full Text] [Related]  

  • 59. Plasma prolactin levels in the male rat after pituitary injection of LH-RH.
    Sandow J; Robyn C
    Acta Endocrinol Suppl (Copenh); 1973; 173():85. PubMed ID: 4579934
    [No Abstract]   [Full Text] [Related]  

  • 60. Hypothalamic-releasing hormones: therapeutic potential of gonadotrophin-releasing hormone: a review.
    Clayton RN
    Q J Med; 1984; 53(209):17-27. PubMed ID: 6369375
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.